LeWine, MD, Chief Medical Editor, Harvard Health Publishing
Patients undergo virtual consultations, receive prescriptions electronically, and have medications delivered to their homes
doi: 10.1126/scitranslmed.adj0052 101 ArvidssonACollinTKirikDKokaiaZLindvallO
The Ethical Questions GLP-1 drugs represent a genuine medical breakthrough for many people struggling with obesity and metabolic disease
Key Takeaways Semaglutides Indian patent expired on 20 March 2026, and generic versions now cost roughly 5090% less than branded Ozempic a big part of why the GLP-1 drugs cost in India has fallen so fast
They help control blood sugar, support weight loss, and can lower the risk of heart and kidney problems and improve liver disease for some people